The Correlation Between Essential Amino Acid Tryptophan, Lysine, Phenylalanine and Chemotherapy of Breast Cancer
Open Access
- 1 January 2024
- journal article
- research article
- Published by SAGE Publications in Technology in Cancer Research & Treatment
- Vol. 23
Abstract
To investigate the differences in serum tryptophan, lysine, and phenylalanine levels in breast cancer patients, the correlation between the three amino acids with the chemotherapy regimen, and their significance in the clinical diagnosis and treatment of breast cancer. Clinical data were collected from the Department of Breast Surgery at Yunnan Cancer Hospital, encompassing 216 cases from July to December 2020, including 91 healthy individuals, 38 with benign tumors, and 87 with cancer. Amino acid levels were measured using liquid chromatography-tandem mass spectrometry. Statistical analyses, such as the Kruskal-Wallis H-test and Wilcoxon test, were conducted to compare the levels of these amino acids across the healthy group, benign tumor group, and breast cancer group. The χ2 test and Fisher's exact probability method were employed to assess the relationship between amino acid levels and breast cancer stage, grade, and chemotherapy regimen. The results indicated that there were significant differences in serum lysine (H = 36.13, P < .001) and phenylalanine (H = 34.03, P < .001) levels among the three groups. However, tryptophan levels did not show statistically significant variances. Specifically, lysine and phenylalanine levels were significantly different when comparing the healthy group with the breast cancer group and the benign tumor group with the breast cancer group. These differences were not significant when comparing the healthy group with the benign tumor group. Furthermore, there were no statistically significant distinctions observed in lysine (F = 0.836, P > .05) and phenylalanine (F = 1.466, P > .05) levels across different conventional chemotherapy regimens among the breast cancer cases studied. Serum lysine and phenylalanine levels might serve as potential biomarkers for breast cancer, and the choice of chemotherapy regimen is unlikely to impact significant changes in these amino acid levels.Keywords
Funding Information
- cience and Technology Project of Yunnan Provincial Science and Technology Department (no.202001AU070053, 202001AU070093 and 202201AY0700)
- Wu Jieping Medical Foundation (no.320.6750.2022-19-58)
- National Natural Science Foundation of China (no. 81960542, 82360614 and 81960517)
- Beijing Science and Technology Innovation Medical Development Foundation (no. KC2021-JK-0044-6)
- Yunnan Health Training Project of High Level Talents (no.H-2019075)
This publication has 37 references indexed in Scilit:
- A Comprehensive Analysis of Metabolomics and Transcriptomics in Cervical CancerScientific Reports, 2017
- Pharmacometabolomics study identifies circulating spermidine and tryptophan as potential biomarkers associated with the complete pathological response to trastuzumab-paclitaxel neoadjuvant therapy in HER-2 positive breast cancerOncotarget, 2016
- A dried blood spot mass spectrometry metabolomic approach for rapid breast cancer detectionOncoTargets and Therapy, 2016
- Perioperative dynamics and significance of amino acid profiles in patients with cancerJournal of Translational Medicine, 2015
- Amino Acids and Immune Response: A Role for Cysteine, Glutamine, Phenylalanine, Tryptophan and Arginine in T-cell Function and Cancer?Pathology and Oncology Research, 2014
- A serum nuclear magnetic resonance-based metabolomic signature of advanced metastatic human breast cancerCancer Letters, 2014
- A diabetes-predictive amino acid score and future cardiovascular diseaseEuropean Heart Journal, 2012
- Identification of a serum-detectable metabolomic fingerprint potentially correlated with the presence of micrometastatic disease in early breast cancer patients at varying risks of disease relapse by traditional prognostic methodsAnnals of Oncology, 2011
- Understanding the role of tryptophan and serotonin metabolism in gastrointestinal functionNeurogastroenterology & Motility, 2009
- The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: Guidelines for Reporting Observational StudiesAnnals of Internal Medicine, 2007